SLC7A11 and myeloid sarcoma: We hypothesize that glutamate release via system xc− on CNS-invading immune cells participates in excitotoxicity and contributes to MS pathology and that preventing the induction of xCT in inflammatory cells rather than inhibiting system xc− pharmacologically might be a promising strategy to treat inflammatory CNS demyelination.